Literature DB >> 15276870

Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue.

Chie Yanagida1, Kousei Ito, Izumi Komiya, Toshiharu Horie.   

Abstract

Fosfomycin is clinically recognized to reduce the aminoglycoside antibiotics-induced nephrotoxicity. However, little has been clarified why fosfomycin protects the kidney from the aminoglycosides-induced nephrotoxicity. Gentamicin, a typical aminoglycoside, is reported to cause lipid peroxidation. We focused on lipid peroxidation induced by gentamicin as a mechanism for the aminoglycosides-induced nephrotoxicity. The aim of this study is to investigate the effect of fosfomycin on the gentamicin-induced lipid peroxidation. In rat renal cortex mitochondria, fosfomycin was shown to depress the gentamicin-induced lipid peroxidation, which was evaluated by formation of thiobarbituric acid reactive substances (TBARS). Interestingly, this effect was observed in rat renal cortex mitochondria, but not in rat liver microsomes. However, fosfomycin did not affect lipid peroxidation of arachidonic acid caused by gentamicin with iron. Fosfomycin inhibited the gentamicin-induced iron release from rat renal cortex mitochondria. These results indicated that fosfomycin inhibited the gentamicin-induced lipid peroxidation by depressing the iron release from mitochondria. This may possibly be one mechanism for the protection of fosfomycin against the gentamicin-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276870     DOI: 10.1016/j.cbi.2004.05.005

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

1.  In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.

Authors:  Xiuzhen Di; Rui Wang; Bin Liu; Xin Zhang; Wentao Ni; Jin Wang; Beibei Liang; Yun Cai; Youning Liu
Journal:  J Antibiot (Tokyo)       Date:  2015-03-25       Impact factor: 2.649

2.  Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae.

Authors:  Miao Zhao; Zackery P Bulman; Justin R Lenhard; Michael J Satlin; Barry N Kreiswirth; Thomas J Walsh; Amanda Marrocco; Phillip J Bergen; Roger L Nation; Jian Li; Jing Zhang; Brian T Tsuji
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

3.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

4.  Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations.

Authors:  María Díez-Aguilar; María Isabel Morosini; Ana P Tedim; Irene Rodríguez; Zerrin Aktaş; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

5.  Rosiglitazone, peroxisome proliferator receptor-gamma agonist, ameliorates gentamicin-induced nephrotoxicity in rats.

Authors:  Emin Ozbek; Yusuf Ozlem Ilbey; Abdulmuttalip Simsek; Mustafa Cekmen; Fatih Mete; Adnan Somay
Journal:  Int Urol Nephrol       Date:  2009-09-25       Impact factor: 2.370

6.  Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats.

Authors:  Nenad Stojiljković; Slavimir Veljković; Dragan Mihailović; Milan Stoiljković; Goran Ranković; Ivan Jovanović; Pavle Randjelović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

7.  Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.

Authors:  Zackery P Bulman; Miao Zhao; Michael J Satlin; Liang Chen; Barry N Kreiswirth; Thomas J Walsh; Roger L Nation; Jian Li; Brian T Tsuji
Journal:  Int J Antimicrob Agents       Date:  2018-02-24       Impact factor: 5.283

Review 8.  Fosfomycin and nitrofurantoin: classic antibiotics and perspectives.

Authors:  Cristiane Dos Santos; Lucas Souza Dos Santos; Octávio Luiz Franco
Journal:  J Antibiot (Tokyo)       Date:  2021-07-09       Impact factor: 2.649

9.  Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.

Authors:  H Malekinejad; A Nikibakhsh; S Gholizadeh-Soltani; A Farshid
Journal:  Indian J Nephrol       Date:  2012-01

10.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

Authors:  David L MacLeod; Lynn M Barker; Jennifer L Sutherland; Suzanne C Moss; Jesse L Gurgel; Thomas F Kenney; Jane L Burns; William R Baker
Journal:  J Antimicrob Chemother       Date:  2009-08-13       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.